{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:09:42Z","timestamp":1790932182296,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s11373-007-9153-7","type":"journal-article","created":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T18:42:52Z","timestamp":1174416172000},"page":"313-322","source":"Crossref","is-referenced-by-count":71,"title":["Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model"],"prefix":"10.1186","volume":"14","author":[{"given":"Li-Ju","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,21]]},"reference":[{"key":"9153_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"J.H. Chang","year":"2001","unstructured":"Chang J.H., Gabison E.E., Kato T., Azar D.T. Corneal neovascularization. Curr. Opin. Ophthalmol. 12: 242\u2013249, 2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"9153_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00007890-198807000-00003","volume":"46","author":"J.C. Hill","year":"1988","unstructured":"Hill J.C., Maske R. An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation 46: 26\u201330, 1988","journal-title":"Transplantation"},{"key":"9153_CR3","first-page":"1954","volume":"38","author":"D. BenEzra","year":"1997","unstructured":"BenEzra D., Griffin B.W., Maftzir G., Sharif N.A., Clark A.F. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 38: 1954\u20131962, 1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9153_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02713689508999908","volume":"14","author":"G.C. Boneham","year":"1995","unstructured":"Boneham G.C., Collin H.B. Steroid inhibition of limbal blood and lymphatic vascular cell growth. Curr. Eye Res. 14: 1\u201310, 1995","journal-title":"Curr. Eye Res."},{"key":"9153_CR5","first-page":"154","volume":"41","author":"T. Suzuki","year":"2000","unstructured":"Suzuki T., Sano Y., Kinoshita S. Effects of 1alpha,25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice. Invest. Ophthalmol. Vis. Sci. 41: 154\u2013158, 2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9153_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00003226-199807000-00011","volume":"17","author":"M.R. Dana","year":"1998","unstructured":"Dana M.R., Zhu S.N., Yamada J. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 17: 403\u2013409, 1998","journal-title":"Cornea"},{"key":"9153_CR7","first-page":"274","volume":"38","author":"U. Benelli","year":"1997","unstructured":"Benelli U., Ross J.R., Nardi M., Klintworth G.K. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest. Ophthalmol. Vis. Sci. 38: 274\u2013282, 1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9153_CR8","first-page":"2498","volume":"40","author":"Z. Duenas","year":"1999","unstructured":"Duenas Z., Torner L., Corbacho A.M., Ochoa A., Gutierrez-Ospina G., Lopez-Barrera F., Barrios F.A., Berger P., Martinez de la Escalera G., Clapp C. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest. Ophthalmol. Vis. Sci. 40: 2498\u20132505, 1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9153_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/00003226-200211000-00007","volume":"21","author":"Y.J. Gordon","year":"2002","unstructured":"Gordon Y.J., Mann R.K., Mah T.S., Gorin M.B. Fluorescein-potentiated argon laser therapy improves symptoms and appearance of corneal neovascularization. Cornea 21: 770\u2013773, 2002","journal-title":"Cornea"},{"key":"9153_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00003226-200307000-00018","volume":"22","author":"M. Fossarello","year":"2003","unstructured":"Fossarello M., Peiretti E., Zucca I., Serra A. Photodynamic therapy of corneal neovascularization with verteporfin. Cornea 22: 485\u2013488, 2003","journal-title":"Cornea"},{"key":"9153_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJM200007133430202","volume":"343","author":"R.J. Tsai","year":"2000","unstructured":"Tsai R.J., Li L.M., Chen J.K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N. Engl. J. Med. 343: 86\u201393, 2000","journal-title":"N. Engl. J. Med."},{"key":"9153_CR12","first-page":"1822","volume":"40","author":"D.H. Ma","year":"1999","unstructured":"Ma D.H., Tsai R.J., Chu W.K., Kao C.H., Chen J.K. Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells. Invest. Ophthalmol. Vis. Sci. 40: 1822\u20131828, 1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9153_CR13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archopht.120.8.1063","volume":"120","author":"B.K. Ambati","year":"2002","unstructured":"Ambati B.K., Joussen A.M., Ambati J., Moromizato Y., Guha C., Javaherian K., Gillies S., O\u2019Reilly M.S, Adamis A.P. Angiostatin inhibits and regresses corneal neovascularization. Arch. Ophthalmol. 120: 1063\u20131068, 2002","journal-title":"Arch. Ophthalmol."},{"key":"9153_CR14","first-page":"2510","volume":"42","author":"A.M. Joussen","year":"2001","unstructured":"Joussen A.M., Beecken W.D., Moromizato Y., Schwartz A., Kirchhof B., Poulaki V. Inhibition of inflammatory corneal angiogenesis by TNP-470. Invest. Ophthalmol. Vis. Sci. 42: 2510\u20132516, 2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9153_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1006\/exer.1997.0292","volume":"64","author":"B.M. Kenyon","year":"1997","unstructured":"Kenyon B.M., Browne F., D\u2019Amato R.J. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp. Eye Res. 64: 971\u2013978, 1997","journal-title":"Exp. Eye Res."},{"key":"9153_CR16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/00003226-200007000-00025","volume":"19","author":"C. Cursiefen","year":"2000","unstructured":"Cursiefen C., Rummelt C., Kuchle M. Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization. Cornea 19: 526\u2013533, 2000","journal-title":"Cornea"},{"key":"9153_CR17","first-page":"18","volume":"39","author":"S. Amano","year":"1998","unstructured":"Amano S., Rohan R., Kuroki M., Tolentino M., Adamis A.P. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 39: 18\u201322, 1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9153_CR18","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/S0959-8049(96)00423-6","volume":"32A","author":"J. Folkman","year":"1996","unstructured":"Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur. J. Cancer 32A: 2534\u20132539, 1996","journal-title":"Eur. J. Cancer"},{"key":"9153_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.gt.3301616","volume":"9","author":"H.I. Ma","year":"2002","unstructured":"Ma H.I., Lin S.Z., Chiang Y.H., Li J., Chen S.L., Tsao Y.P., Xiao X. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector. Gene Ther. 9: 2\u201311, 2002","journal-title":"Gene Ther."},{"key":"9153_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0006-2952(00)00529-3","volume":"61","author":"S. Liekens","year":"2001","unstructured":"Liekens S., De Clercq E., Neyts J. Angiogenesis: regulators and clinical applications. Biochem. Pharmacol. 61: 253\u2013270, 2001","journal-title":"Biochem. Pharmacol."},{"key":"9153_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"M.S. O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E.B., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277\u2013285, 1997","journal-title":"Cell"},{"key":"9153_CR22","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/annonc\/mdi318","volume":"16","author":"A.H. Hansma","year":"2005","unstructured":"Hansma A.H., Broxterman H.J., van der Horst I., Yuana Y., Boven E., Giaccone G., Pinedo H.M., Hoekman K. Recombinant human endostatin administered as a 28\u00a0day continuous intravenous infusion, followed by daily subcutaneous injections: a phase 1 and pharmacokinetic study in patients with advanced cancer. Ann. Oncol. 16: 1695\u20131701, 2005","journal-title":"Ann. Oncol."},{"key":"9153_CR23","first-page":"1809","volume":"117","author":"Z.H. Liang","year":"2004","unstructured":"Liang Z.H., Wu P.H., Li L., Xue G., Zeng Y.X., Huang W.L. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein. Chin. Med. J. 117: 1809\u20131814, 2004","journal-title":"Chin. Med. J."},{"key":"9153_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ijrobp.2005.01.038","volume":"63","author":"X. Luo","year":"2005","unstructured":"Luo X., Stater J.M., Gridley D.S. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model. Int. J. Rad. Oncol. Biol. Phys. 63: 553\u2013564, 2005","journal-title":"Int. J. Rad. Oncol. Biol. Phys."},{"key":"9153_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00001813-200506000-00011","volume":"16","author":"Y. Wu","year":"2005","unstructured":"Wu Y., Yang L., Hu B., Liu J.Y., Su K.M., Luo Y., Dino Z.Y., Niu T., Li Q., Xie X.J., Wen Y.J., Tian L., Kan B., Mao Y.Q., Wei Y.Q. Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine. Anti-Cancer Drugs 16: 551\u2013557, 2005","journal-title":"Anti-Cancer Drugs"},{"key":"9153_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/sj.cgt.7700740","volume":"11","author":"M. Uesato","year":"2004","unstructured":"Uesato M., Gunji Y., Tomonaga T., Miyazaki S., Shiratori T., Matsubara H., Kouzu T., Shimada H., Nomura F., Ochiai T. Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation. Cancer Gene Ther 11: 625\u2013632, 2004","journal-title":"Cancer Gene Ther"},{"key":"9153_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00423-003-0400-8","volume":"388","author":"R. Kurdow","year":"2003","unstructured":"Kurdow R., Boehle A.S., Ruhnke M., Mendoza R., Boenicke L., Sipos B., Schniewind B., Dohrmann P., Kalthoff H.H. Retroviral endostatin gene transfer inhibits growth of human lung cancer in a murine orthotopic xenotransplant model. Langenbecks Arch. Surg. 388: 401\u2013405, 2003","journal-title":"Langenbecks Arch. Surg."},{"key":"9153_CR28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/ard.62.7.677","volume":"62","author":"D. Kurosaka","year":"2003","unstructured":"Kurosaka D., Yoshida K., Yasuda J., Yokoyama T., Kingetsu I., Yamaguchi N., Joh K., Matsushima M., Saito S., Yamada A. Inhibition of arthritis by systemic administration of endostatin in passive murine collagen induced arthritis. Ann. Rheum. Dis. 62: 677\u2013679, 2003","journal-title":"Ann. Rheum. Dis."},{"key":"9153_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1023\/A:1021540328613","volume":"5","author":"S.P. Jung","year":"2002","unstructured":"Jung S.P., Siegrist B., Hornick C.A., Wang Y.Z., Wade M.R., Anthony C.T., Woltering E.A. Effect of human recombinant Endostatin protein on human angiogenesis. Angiogenesis 5: 111\u2013118, 2002","journal-title":"Angiogenesis"},{"key":"9153_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1200\/JCO.2003.12.120","volume":"21","author":"J.P. Thomas","year":"2003","unstructured":"Thomas J.P., Arzoomanian R.Z., Alberti D., Marnocha R., Lee F., Friedl A., Tstsch K., Dresen A., Geiger P., Pluda J., Fogler W., Schiller J.H., Wilding G. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. J. Clin. Oncol. 21: 223\u2013231, 2003","journal-title":"J. Clin. Oncol."},{"key":"9153_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1358\/mf.2003.25.3.769643","volume":"25","author":"B. Ren","year":"2003","unstructured":"Ren B., Hoti N., Rabasseda X., Wang Y.Z., Wu M. The antiangiogenic and therapeutic implications of endostatin. Methods Find Exp. Clin. Pharmacol. 25: 215\u2013224, 2003","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"9153_CR32","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/JVI.70.11.8098-8108.1996","volume":"70","author":"X. Xiao","year":"1996","unstructured":"Xiao X., Li J., Samulski R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70: 8098\u20138108, 1996","journal-title":"J. Virol."},{"key":"9153_CR33","doi-asserted-by":"publisher","first-page":"13714","DOI":"10.1073\/pnas.240335297","volume":"97","author":"B. Wang","year":"2000","unstructured":"Wang B., Li J., Xiao X. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl. Acad. Sci. USA 97: 13714\u201313719, 2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9153_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/sj.gt.3300830","volume":"6","author":"J. Li","year":"1999","unstructured":"Li J., Dressman D., Tsao Y.P., Sakamoto A., Hoffman E.P., Xiao X. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy. Gene Ther. 6: 74\u201382, 1999","journal-title":"Gene Ther."},{"key":"9153_CR35","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","volume":"8","author":"D.M. McCarty","year":"2001","unstructured":"McCarty D.M., Monahan P.E., Samulski R.J. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8: 1248\u20131254, 2001","journal-title":"Gene Ther."},{"key":"9153_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1094-148","volume":"8","author":"M.G. Kaplitt","year":"1994","unstructured":"Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O\u2019Malley K.L., During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8: 148\u2013154, 1994","journal-title":"Nat. Genet."},{"key":"9153_CR37","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1128\/JVI.72.11.8568-8577.1998","volume":"72","author":"D. Duan","year":"1998","unstructured":"Duan D., Sharma P., Yang J., Yue Y., Dudus L., Zhang Y., Fisher K.J., Engelhardt J.F. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72: 8568\u20138577, 1998","journal-title":"J. Virol."},{"key":"9153_CR38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1165\/ajrcmb.11.5.7946381","volume":"11","author":"T.R. Flotte","year":"1994","unstructured":"Flotte T.R., Afione S.A., Zeitlin P.L. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11: 517\u2013521, 1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"9153_CR39","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","volume":"72","author":"X. Xiao","year":"1998","unstructured":"Xiao X., Li J., Samulski R.J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72: 2224\u20132232, 1998","journal-title":"J. Virol."},{"key":"9153_CR40","first-page":"756","volume":"62","author":"H.I. Ma","year":"2002","unstructured":"Ma H.I., Guo P., Li J., Lin S.Z., Chiang Y.H., Xiao X., Cheng S.Y. Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin. Cancer Res. 62: 756\u2013763, 2002","journal-title":"Cancer Res."},{"key":"9153_CR41","first-page":"751","volume":"43","author":"M.L. Tsai","year":"2002","unstructured":"Tsai M.L., Chen S.L., Chou P.I., Wen L.Y., Tsai R.J.F., Tsao Y.P. Inducible adenoassociated virus vector-delivered transgene expression in corneal endothelium. Invest. Ophthalmol. Vis. Sci. 43: 751\u2013757, 2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9153_CR42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1006\/exer.1998.0557","volume":"67","author":"K. Tsubota","year":"1998","unstructured":"Tsubota K., Inoue H., Ando K., Ono M., Yoshino K., Saito I. Adenovirus-mediated gene transfer to the ocular surface epithelium. Exp. Eye Res. 67: 531\u2013538, 1998","journal-title":"Exp. Eye Res."},{"key":"9153_CR43","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1089\/104303401750270959","volume":"12","author":"C.M. Lai","year":"2001","unstructured":"Lai C.M., Brankov M., Zaknich T., Lai Y.K., Shen W.Y., Constable I.J., Kovesdi I., Rakoczy P.E. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Hum. Gene Ther. 12: 1299\u20131310, 2001","journal-title":"Hum. Gene Ther."},{"key":"9153_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drup.2005.03.001","volume":"8","author":"A. Abdollahi","year":"2005","unstructured":"Abdollahi A., Hlatky L., Huber P.E. Endostatin: the logic of antiangiogenic therapy. Drug Resist Updat 8: 59\u201374, 2005","journal-title":"Drug Resist Updat"},{"key":"9153_CR45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1006\/mthe.2002.0702","volume":"6","author":"A. Auricchio","year":"2002","unstructured":"Auricchio A., Behling K.C., Maguire A.M., O\u2019Connor E.M., Bennett J., Wilson J.M., Tolentino M.J. Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents. Mol. Ther. 6: 490\u2013494, 2002","journal-title":"Mol. Ther."},{"key":"9153_CR46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2337\/diabetes.55.04.06.db05-0927","volume":"55","author":"Z. Wang","year":"2006","unstructured":"Wang Z., Zhu T., Rehman K.K., Bertera S., Zhang J., Chen C., Papworth G., Watkins S., Trucco M., Robbins P.D., Li J., Xiao X. Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes. Diabetes 55: 875\u2013884, 2006","journal-title":"Diabetes"},{"key":"9153_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/jsre.2000.5890","volume":"91","author":"A.C. Berger","year":"2000","unstructured":"Berger A.C., Feldman A.L., Gnant M.F., Kruger E.A., Sim B.K., Hewitt S., Figg W.D., Alexander H.R., Libutti S.K. The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. J. Surg. Res. 91: 26\u201331, 2000","journal-title":"J. Surg. Res."},{"key":"9153_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nbt1073","volume":"23","author":"Z. Wang","year":"2003","unstructured":"Wang Z., Zhu T., Qiao C., Zhou L., Wang B., Zhang J., Chen C., Li J., Xiao X. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotech. 23: 321\u2013328, 2003","journal-title":"Nat. Biotech."}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11373-007-9153-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11373-007-9153-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T01:11:49Z","timestamp":1587431509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11373-007-9153-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,21]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["9153"],"URL":"https:\/\/doi.org\/10.1007\/s11373-007-9153-7","relation":{},"ISSN":["1021-7770","1423-0127"],"issn-type":[{"value":"1021-7770","type":"print"},{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,21]]}}}